Enact Holdings (ACT)
(Delayed Data from NSDQ)
$29.95 USD
+0.01 (0.03%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $29.96 +0.01 (0.03%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Income Statements
Fiscal Year end for Enact Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,154 | 1,095 | 1,118 | 1,106 | 979 |
Cost Of Goods | 240 | 133 | 357 | 595 | 246 |
Gross Profit | 914 | 962 | 761 | 512 | 733 |
Selling & Adminstrative & Depr. & Amort Expenses | 11 | 12 | 15 | 21 | 15 |
Income After Depreciation & Amortization | 903 | 950 | 746 | 491 | 718 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 52 | 52 | 51 | 18 | 0 |
Pretax Income | 852 | 898 | 695 | 472 | 718 |
Income Taxes | 186 | 194 | 149 | 102 | 156 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 115 |
Income From Cont. Operations | 666 | 704 | 547 | 370 | 678 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 666 | 704 | 547 | 370 | 678 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 910 | 962 | 755 | 506 | 731 |
Depreciation & Amortization (Cash Flow) | 7 | 12 | 8 | 16 | 12 |
Income After Depreciation & Amortization | 903 | 950 | 746 | 491 | 718 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 161.85 | 163.29 | 163.19 | NA | NA |
Diluted EPS Before Non-Recurring Items | 4.18 | 4.34 | 3.37 | NA | NA |
Diluted Net EPS (GAAP) | 4.11 | 4.31 | 3.36 | 2.27 | NA |
Fiscal Year end for Enact Holdings, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 296.19 | 299.04 | 277.52 | 280.94 |
Cost Of Goods | NA | 80.93 | 70.19 | 47.82 | 40.72 |
Gross Profit | NA | 215.26 | 228.85 | 229.71 | 240.22 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2.57 | 2.80 | 2.65 | 2.64 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 212.69 | 226.05 | 227.06 | 237.58 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 12.95 | 12.94 | 12.91 | 13.07 |
Pretax Income | NA | 199.74 | 213.11 | 214.15 | 224.51 |
Income Taxes | NA | 42.44 | 48.91 | 46.13 | 48.53 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 157.31 | 164.20 | 168.02 | 175.99 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 157.31 | 164.20 | 168.02 | 175.99 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 160.90 | 161.15 | 162.17 | 163.18 |
Diluted EPS Before Non-Recurring Items | NA | 0.98 | 1.02 | 1.10 | 1.08 |
Diluted Net EPS (GAAP) | NA | 0.97 | 1.02 | 1.04 | 1.08 |